| Product Code: ETC8872683 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Sarilumab Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Sarilumab Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Sarilumab Market - Industry Life Cycle |
3.4 Poland Sarilumab Market - Porter's Five Forces |
3.5 Poland Sarilumab Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.6 Poland Sarilumab Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.7 Poland Sarilumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Poland Sarilumab Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 Poland Sarilumab Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Poland Sarilumab Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
4 Poland Sarilumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rheumatoid arthritis in Poland |
4.2.2 Growing awareness and adoption of biologic therapies |
4.2.3 Favorable reimbursement policies for sarilumab in Poland |
4.3 Market Restraints |
4.3.1 Competition from other biologic drugs in the market |
4.3.2 High cost associated with sarilumab treatment |
4.3.3 Potential side effects and safety concerns related to sarilumab usage |
5 Poland Sarilumab Market Trends |
6 Poland Sarilumab Market, By Types |
6.1 Poland Sarilumab Market, By End-Users |
6.1.1 Overview and Analysis |
6.1.2 Poland Sarilumab Market Revenues & Volume, By End-Users, 2021- 2031F |
6.1.3 Poland Sarilumab Market Revenues & Volume, By Clinic, 2021- 2031F |
6.1.4 Poland Sarilumab Market Revenues & Volume, By Hospital, 2021- 2031F |
6.1.5 Poland Sarilumab Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Poland Sarilumab Market, By Demographic |
6.2.1 Overview and Analysis |
6.2.2 Poland Sarilumab Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.3 Poland Sarilumab Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.3 Poland Sarilumab Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Poland Sarilumab Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.3.3 Poland Sarilumab Market Revenues & Volume, By Community-acquired Pneumonia, 2021- 2031F |
6.3.4 Poland Sarilumab Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Poland Sarilumab Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 Poland Sarilumab Market Revenues & Volume, By Antirheumatic, 2021- 2031F |
6.4.3 Poland Sarilumab Market Revenues & Volume, By Interleukin-6 Receptor Antagonist, 2021- 2031F |
6.4.4 Poland Sarilumab Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.5 Poland Sarilumab Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Poland Sarilumab Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.5.3 Poland Sarilumab Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6 Poland Sarilumab Market, By Dosage |
6.6.1 Overview and Analysis |
6.6.2 Poland Sarilumab Market Revenues & Volume, By Injection, 2021- 2031F |
6.6.3 Poland Sarilumab Market Revenues & Volume, By Solution, 2021- 2031F |
7 Poland Sarilumab Market Import-Export Trade Statistics |
7.1 Poland Sarilumab Market Export to Major Countries |
7.2 Poland Sarilumab Market Imports from Major Countries |
8 Poland Sarilumab Market Key Performance Indicators |
8.1 Patient adherence rate to sarilumab treatment |
8.2 Number of healthcare providers prescribing sarilumab |
8.3 Patient satisfaction and reported quality of life improvements post sarilumab treatment |
9 Poland Sarilumab Market - Opportunity Assessment |
9.1 Poland Sarilumab Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.2 Poland Sarilumab Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.3 Poland Sarilumab Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Poland Sarilumab Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 Poland Sarilumab Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Poland Sarilumab Market Opportunity Assessment, By Dosage, 2021 & 2031F |
10 Poland Sarilumab Market - Competitive Landscape |
10.1 Poland Sarilumab Market Revenue Share, By Companies, 2024 |
10.2 Poland Sarilumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here